Please assess the completion status of the following clinical trial:

Trial Title: Does Low-does Cervical Epidural Lidocaine Cause Transient Weakness?

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Age 18-80.~2. Clinical diagnosis of cervical radicular pain.~3. Magnetic resonance imaging pathology consistent with clinical symptoms/signs.~4. Numerical Rating Scale (NRS) pain score of 4 or higher.~5. Pain duration of more than 6 weeks despite trial of conservative therapy (medications, physical therapy, or chiropractic care).~6. Patients who will undergo CESI for treatment of cervical radiculitis.~Exclusion Criteria:~1. Refusal to participate, provide consent, or provide communication and follow-up information for duration of the study.~2. Inability to perform handgrip or arm strength testing.~3. Contraindications to Cervical ESI (active infection, bleeding disorders, current anticoagulant or antiplatelet medication use, allergy to medications used for CIESI, and pregnancy).~4. Current glucocorticoid use or ESI within past 6 months.~5. Prior cervical spine surgery.~6. Cervical spinal cord lesions; cerebrovascular, demyelinating, or other neuro-muscular muscular disease.~7. Patient request for or requirement of conscious sedation for the injection procedure.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- cervical interlaminar with lidocaine (Type: ACTIVE_COMPARATOR): Group #1: Interlaminar cervical ESI at the C7-T1 level with triamcinolone acetonide 80 mg (40 mg/mL) + 2 mL 1% lidocaine (total volume 4 mL).
- cervical interlaminar with normal saline (Type: ACTIVE_COMPARATOR): Group #2: Interlaminar cervical ESI at the C7-T1 level with triamcinolone acetonide 80 mg (40 mg/mL) + 2 mL preservative saline (total volume 4 mL).

Based on this trial design, predict the completion outcome and termination type (if applicable).